Canadian Cancer Trials Group Bulletins


Precision Oncology takes a step forward at CCTG

The Canadian Foundation for Innovation (CFI) John R. Evans Leaders Fund (JELF) has announced a funding award of $197,065 to allow the Canadian Cancer Trials Group (CCTG) to acquire a state-of-the-art digital histology slide scanner. The scanner will enable CCTG to share digitized scans of slides from tumour specimens with expert pathologists across Canada, enlisting their expertise in diagnosis and classification of tumours as well as quantify new biomarkers that could lead to improved treatments.

Read more here.